[BREAKING] [Breaking news] Lee Jaeyong's business trip to the U.S. highlighted the issue of joint development of a treatment for COVID-19 with Samsung Biologics.

5 October Share

[BREAKING] [Breaking news] Lee Jaeyong's business trip to the U.S. highlighted the issue of joint development of a treatment for COVID-19 with Samsung Biologics.

［速報］李在鎔、米国出張に三星バイオロジックスとダイノナ治療剤の共同開発問題が浮上

[快讯] 李在镕出差美国时，三星生物制剂和Dynona新冠病毒治疗剂共同开发成为焦点

В командировке в США Samsung Bio Logics и Dynona Corona не обсуждают вопросы совместной разработки лечения.

[속보] 이재용 미국 출장에 삼성바이오로직스와 다이노나 코로나 치료제 공동개발 이슈부각 [More News]